Planning and Incentives for Traumatic Brain Injury
Trial Summary
What is the purpose of this trial?
The purpose of this research is to learn if different behavioral interventions can change walking behaviors over 12-weeks, in older adults who have previously suffered a non-penetrating mild or moderate TBI. Participants will provide information and be screened for eligibility via phone screening call (verification of age, confirmation that the participant is not currently on any medication that affects the central nervous system, and verification that the subject can participate in exercise, brief TBI history). Baseline testing will take place at the Center for Cognitive and Brain Health and Northeastern University Biomedical Imaging Center, for the baseline magnetic resonance imaging, in the interdisciplinary science and engineering complex on Northeastern University's campus. In person testing will take place over one session. The study period lasts 12 weeks, during which all participants will 1. Receive a weekly phone call with study staff and 2. Wear a wrist-worn Fit Bit tracker. A remote participation option is available for those who cannot travel to Northeastern University.
Will I have to stop taking my current medications?
The trial requires that participants are not currently on any medication that affects the central nervous system. If you are taking such medications, you may need to stop them to participate.
What data supports the effectiveness of the treatment Planning and Incentives for Traumatic Brain Injury?
Is the treatment generally safe for humans?
How is the treatment 'Planning and Incentives for Traumatic Brain Injury' different from other treatments for TBI?
This treatment is unique because it combines health education, planning, reminders, and micro-incentives to encourage rehabilitation after a traumatic brain injury. Unlike traditional treatments, it uses small rewards to boost motivation and participation in rehabilitation activities, which can be particularly effective for individuals with memory challenges.910111213
Research Team
Eligibility Criteria
This trial is for older adults who have had a mild or moderate non-penetrating traumatic brain injury (TBI). They must be able to exercise, not on central nervous system medications, and willing to attend baseline testing at Northeastern University. Specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline testing including MRI and cognitive assessments
Treatment
Participants receive behavioral interventions over 12 weeks, including weekly phone calls and wearing a Fit Bit
Follow-up
Participants complete post-testing remotely, including cognitive tasks and questionnaires
Treatment Details
Interventions
- Health Education (Behavioural Intervention)
- Planning, Reminders, and Micro-Incentives (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northeastern University
Lead Sponsor
Jared Auclair
Northeastern University
Chief Executive Officer
PhD in Biomedical Science from the University of Massachusetts Medical School
Anantdeep Kaur
Northeastern University
Chief Medical Officer since 2023
Master’s and Doctorate in Biotechnology from the University of Technology Sydney
Timothy Morris
Lead Sponsor
Brandeis University
Collaborator
National Institute on Aging (NIA)
Collaborator
Dr. Richard J. Hodes
National Institute on Aging (NIA)
Chief Executive Officer since 1993
MD from Harvard Medical School
Dr. Marie Bernard
National Institute on Aging (NIA)
Chief Medical Officer
MD from Harvard Medical School